pirinixic acid has been researched along with Aortic Aneurysm in 1 studies
pirinixic acid: structure
Aortic Aneurysm: An abnormal balloon- or sac-like dilatation in the wall of AORTA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " EXPERIMENTAL APPROACH We determined the effect of LP105, a pirinixic acid derivative which acts as inhibitor of 5-LOX, COX and mPGES-1, on aortic aneurysm development in mice and on 5-LOX activity in murine monocytes." | 7.77 | A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm. ( Brandes, RP; Fischer, AS; Geisslinger, G; Maier, TJ; Mieth, A; Paulke, A; Pellowska, M; Popescu, L; Revermann, M; Schermuly, RT; Schubert-Zsilavecz, M; Steinhilber, D; Steri, R; Wurglics, M, 2011) |
| " EXPERIMENTAL APPROACH We determined the effect of LP105, a pirinixic acid derivative which acts as inhibitor of 5-LOX, COX and mPGES-1, on aortic aneurysm development in mice and on 5-LOX activity in murine monocytes." | 3.77 | A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm. ( Brandes, RP; Fischer, AS; Geisslinger, G; Maier, TJ; Mieth, A; Paulke, A; Pellowska, M; Popescu, L; Revermann, M; Schermuly, RT; Schubert-Zsilavecz, M; Steinhilber, D; Steri, R; Wurglics, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Revermann, M | 1 |
| Mieth, A | 1 |
| Popescu, L | 1 |
| Paulke, A | 1 |
| Wurglics, M | 1 |
| Pellowska, M | 1 |
| Fischer, AS | 1 |
| Steri, R | 1 |
| Maier, TJ | 1 |
| Schermuly, RT | 1 |
| Geisslinger, G | 1 |
| Schubert-Zsilavecz, M | 1 |
| Brandes, RP | 1 |
| Steinhilber, D | 1 |
1 other study available for pirinixic acid and Aortic Aneurysm
| Article | Year |
|---|---|
A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm.
Topics: Administration, Oral; Angiotensin II; Animals; Aorta; Aortic Aneurysm; Arachidonate 5-Lipoxygenase; | 2011 |